ArticleInternational journal of molecular sciences2024

Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.

László Ujlaky-Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.